GAM
SANA icon

Griffin Asset Management’s Sana Biotechnology SANA Stock Holding History

Griffin Asset Management’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$42.1K Buy
14,620
+3,000
+26% +$11.8K ﹤0.01% 224
2025
Q4 		$47.3K Hold
11,620
– – 0.01% 232
2025
Q3 		$41.3K Buy
+11,620
New +$42K ﹤0.01% 224

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MG
Marex Group London $15.8B AUM 31.44% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.09B AUM 112.84% 1-Year Est. Return

Griffin Asset Management's SANA Position: Q1 2026 in Review

Griffin Asset Management increased its Sana Biotechnology (SANA) stake by 26% in Q1 2026, buying an estimated $11.8K and bringing the position to 14,620 shares worth $42.1K. The position accounts for ﹤0.01% of the portfolio, ranked #224.

Griffin Asset Management first reported a position in SANA in Q3 2025 and has held it in 3 quarters since. The position peaked at $47.3K in Q4 2025. 202 funds tracked by Wall St. Rank hold SANA as of Q1 2026.

  • Griffin Asset Management held 14,620 shares of Sana Biotechnology worth $42.1K as of Q1 2026.
  • Griffin Asset Management bought 3,000 Sana Biotechnology shares in Q1 2026, an estimated $11.8K.
  • Sana Biotechnology made up ﹤0.01% of Griffin Asset Management's portfolio in Q1 2026, its #224 holding.
  • Griffin Asset Management first reported a position in Sana Biotechnology in Q3 2025 and has held it in 3 quarters since.
  • Griffin Asset Management's Sana Biotechnology position peaked at $47.3K in Q4 2025.
  • 202 funds tracked by Wall St. Rank held Sana Biotechnology as of Q1 2026.

Based on Griffin Asset Management's 13F filing for Q1 2026, filed 30 Apr 2026.